Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 8/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21924148 | 0.95 | BBOX1 (0.50) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16798956 | 0.94 | TSHR (0.46) | BBOX1TSHRTHRBMAPTBLM | |
| SCHEMBL16798877 | 0.93 | TSHR (0.49) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16798858 | 0.93 | TSHR (0.49) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16799486 | 0.93 | TSHR (0.49) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16798885 | 0.93 | TSHR (0.49) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16798945 | 0.93 | TSHR (0.49) | BBOX1TSHRTHRBPOLBAPEX1 | |
| SCHEMBL16798857 | 0.91 | TSHR (0.50) | BBOX1TSHRTHRBCHRM5CHRM1 | |
| SCHEMBL16798908 | 0.90 | TSHR (0.53) | BBOX1TSHRTHRBMAPTBLM | |
| SCHEMBL16799082 | 0.90 | TSHR (0.53) | BBOX1TSHRTHRBMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-02-10 | — | — | US | disclosed |
| WO-2025070814-A1 | SUGAR CHAIN PREPARATION METHOD AND SUGAR CHAIN ANALYSIS METHOD | 住友ベークライト株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-3896074-B1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | AIST (JP) | 2023-10-25 | — | — | EP | disclosed |
| US-20220017648-A1 | Method, Kit, and Device for Preparing Glycan from Glycoprotein | SUMITOMO BAKELITE CO., LTD. (JP) | 2022-01-20 | — | — | US | disclosed |
| EP-3896074-A1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-10-20 | — | — | EP | disclosed |
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20200216484-A1 | PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF | SUMITOMO BAKELITE CO., LTD. (JP) | 2020-07-09 | — | — | US | disclosed |
| WO-2020122072-A1 | METHOD, KIT, AND DEVICE FOR PREPARING GLYCAN FROM GLYCOPROTEIN | 国立研究開発法人産業技術総合研究所 | 2020-06-18 | — | — | WO | disclosed |
| EP-3650456-A1 | PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF | Sumitomo Bakelite Co., Ltd. (JP) | 2020-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216484-A1 | PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF | FUT5, MANBA, MGAM | BBOX1 227/4885TSHR 2497/4885THRB 711/4885 |
| US-11136344-B2 | Purification agent for sugar chain or glycopeptide, and use thereof | FUT5, MANBA, MGAM | BBOX1 227/4885TSHR 2497/4885THRB 711/4885 |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | FUT7, FUT4, SIGLEC7 | BBOX1 790/4885TSHR 565/4885THRB 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.